| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
||
|---|---|---|
|
February
February; 7 (1): 1 - 89. |
April
April; 7 (2): 92 - 171. Supplement: Novel Approaches to the Treatment of Advanced Hematologic Malignancies. |
June
June; 7 (3): 170 - 266. Supplement: Schwartz Center Rounds: Volume 1. |
|
August
Supplement: Novel Molecular Targets for Cancer Therapy. Supplement: ZD1839 (IressaTM): A New Targeted Therapy for Solid Tumors. August; 7 (4): 269 - 388. |
October
October; 7 (5): 389 - 471. Supplement: Current Perspectives in the Treatment of Ovarian Cancer: An Update on the Role of Topotecan. |
December
December; 7 (6): 475 - 585. Supplement: Incorporating Oral Capecitabine into the Treatment of Breast Cancer. |
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |